SonoVue® (sulphur hexafluoride microbubbles) ? contrast agent for contrast enhanced ultrasound in liver imaging.
Research Project
|
01.10.2011
- 30.06.2012
Health Technology Assessment on Ultrasound for liver imaging. The clinical and cost effectiveness of contrast enhanced ultrasound (CEUS) using the contrast agent SonoVue® for the assessment of adults with focal liver lesions (FLL), in whom previous liver imaging is inconclusive, will be assessed for patients with suspected malignancy in the liver. Project lead will be by Kleijnen Systematic Reviews.